×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement
Barron's
Instead of charging the standard 1% of assets under management, new firms are trying to grab business by charging a fixed annual fee no...
3 months ago
Perspective Therapeutics (NYSEAMERICAN:CATX) Hits New 1-Year High at $1.62
Defense World
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Hits New 1-Year High at $1.62 at Defense World.
6 days ago
Perspective Therapeutics Announces First Patient Dosed in a Phase 1 Study of [(212)Pb]VMT-α-NET to Treat ...
Yahoo Finance
First U.S. patient with refractory or relapsed SSTR2-positive neuroendocrine tumors treated with [212Pb]VMT-α-NETPreliminary data readout...
4 months ago
Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript
Seeking Alpha
Rani Therapeutics Holdings, Inc. (NASDAQ:NASDAQ:RANI) Q4 2023 Earnings Conference Call March 20, 2024 4:30 PM ETCompany ParticipantsKiki...
1 month ago
Blue Earth Therapeutics Announces Promising Results of Preclinical Evaluation of 225Ac-rhPSMA-10.1 for Potential ...
Business Wire
225Actinium-labeled radiohybrid Prostate-Specific Membrane Antigen (225Ac-rhPSMA-10.1) is in development as a highly optimized,...
7 months ago
NorthStar Medical Radioisotopes Announces Supply Agreement with Nucleus RadioPharma for Alpha-emitting ...
Imaging Technology News
July 5, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of...
9 months ago
Jefferies starts Viking Therapeutics at buy, cites "scarcity value" (NASDAQ:VKTX)
Seeking Alpha
Jefferies started coverage of Viking Therapeutics (VKTX) with a buy rating, noting that the drug developer was "enjoying scarcity value in...
1 month ago
Tools for Developing Actinium-225 Therapeutics | Discover Los Alamos National Laboratory
Los Alamos National Lab (.gov)
The concept of using radioactive isotopes for medical applications has become commonplace in the last several decades.
2 months ago
Perspective Therapeutics (NYSEAMERICAN:CATX) Reaches New 12-Month High at $1.60
Defense World
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Reaches New 12-Month High at $1.60 at Defense World.
3 weeks ago
TerraPower Isotopes
TerraPower
TerraPower's assessment shows that select isotopic materials may be effectively used in Targeted Alpha Therapy for cancer patients.
16 months ago